Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hickish

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphomaM Hill, D Cunningham, D MacVicar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 1998
Good symptom relief with palliative MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in malignant mesotheliomaG W Middleton, I E Smith, M E O'Brien, et al.
British Journal of Cancer|September 1, 1993
EPIC: an effective low toxicity regimen for relapsing lymphomaT Hickish, A Roldan, D Cunningham, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
A randomised study of protracted venous infusion of 5-fluorouracil (5-FU) with or without bolus mitomycin C (MMC) in patients with carcinoma of unknown primaryL Assersohn, A R Norman, D Cunningham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracilM Findlay, H Young, D Cunningham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1994
A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF)M Findlay, D Cunningham, A Norman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Impact of protracted venous infusion fluorouracil with or without interferon alfa-2b on tumor response, survival, and quality of life in advanced colorectal cancerM Hill, A Norman, D Cunningham, et al.
Leukemia & Lymphoma|May 1, 1996
Comparison of interferon tolerance after autologous bone marrow or peripheral blood stem cell transplants for myeloma patients who have responded to induction therapyR Powles, N Raje, C Horton, et al.
British Journal of Cancer|January 1, 1993
2'-Chlorodeoxyadenosine: evaluation of a novel predominantly lymphocyte selective agent in lymphoid malignanciesT Hickish, P Serafinowski, D Cunningham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myelomaD Cunningham, L Paz-Ares, S Milan, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphomaM Hill, D Cunningham, D MacVicar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 1998
Good symptom relief with palliative MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in malignant mesotheliomaG W Middleton, I E Smith, M E O'Brien, et al.
British Journal of Cancer|September 1, 1993
EPIC: an effective low toxicity regimen for relapsing lymphomaT Hickish, A Roldan, D Cunningham, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
A randomised study of protracted venous infusion of 5-fluorouracil (5-FU) with or without bolus mitomycin C (MMC) in patients with carcinoma of unknown primaryL Assersohn, A R Norman, D Cunningham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracilM Findlay, H Young, D Cunningham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1994
A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF)M Findlay, D Cunningham, A Norman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Impact of protracted venous infusion fluorouracil with or without interferon alfa-2b on tumor response, survival, and quality of life in advanced colorectal cancerM Hill, A Norman, D Cunningham, et al.
Leukemia & Lymphoma|May 1, 1996
Comparison of interferon tolerance after autologous bone marrow or peripheral blood stem cell transplants for myeloma patients who have responded to induction therapyR Powles, N Raje, C Horton, et al.
British Journal of Cancer|January 1, 1993
2'-Chlorodeoxyadenosine: evaluation of a novel predominantly lymphocyte selective agent in lymphoid malignanciesT Hickish, P Serafinowski, D Cunningham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myelomaD Cunningham, L Paz-Ares, S Milan, et al.
Pageof 7